Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
Clinical trial NCT01158534 · COMPLETED
Trial details
- NCT number
- NCT01158534
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.